An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
This study highlighted the significant potential of the Anoscore in predicting prognosis and guiding the selection of personalized therapeutic regimens for patients with GI cancers.
Authors
- Pengxiang Chen (ORCID: https://orcid.org/0000-0002-7660-4981)
- Wei‐Cheng Huang (ORCID: https://orcid.org/0000-0003-4437-3530)
- Yuchen Liu (ORCID: https://orcid.org/0000-0003-2698-3482)
- Yufeng Cheng (ORCID: https://orcid.org/0000-0001-8342-5802)
- Ruyi Liu
Institutions
- Shandong University (CN)
- Shandong Tumor Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1477913
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China